BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11264730)

  • 1. Expression of interferon-alpha subtypes in peripheral mononuclear cells from patients with chronic hepatitis C: a role for interferon-alpha5.
    Larrea E; Alberdi A; Castelruiz Y; Boya P; Civeira MP; Prieto J
    J Viral Hepat; 2001 Mar; 8(2):103-10. PubMed ID: 11264730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alfa subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls.
    Castelruiz Y; Larrea E; Boya P; Civeira MP; Prieto J
    Hepatology; 1999 Jun; 29(6):1900-4. PubMed ID: 10347136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Interferon Regulatory Factor 2 Gene Expression is Induced in Chronic Hepatitis C Virus Infection-A Possible Mode of Viral Persistence.
    Mukherjee RM; Bansode B; Gangwal P; Jakkampudi A; Reddy PB; Rao PN; Gupta R; Nageshwar Reddy D
    J Clin Exp Hepatol; 2012 Mar; 2(1):27-34. PubMed ID: 25755403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The detection of IRF-1 promoter polymorphisms and their possible contribution to T helper 1 response in chronic hepatitis C.
    Saito H; Tada S; Wakabayashi K; Nakamoto N; Takahashi M; Nakamura M; Ebinuma H; Ishii H
    J Interferon Cytokine Res; 2002 Jun; 22(6):693-700. PubMed ID: 12162881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C.
    Massirer KB; Hirata MH; Silva AE; Ferraz ML; Nguyen NY; Hirata RD
    Braz J Med Biol Res; 2004 May; 37(5):643-7. PubMed ID: 15107924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.
    Feng X; Petraglia AL; Chen M; Byskosh PV; Boos MD; Reder AT
    J Neuroimmunol; 2002 Aug; 129(1-2):205-15. PubMed ID: 12161037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interferons-alpha and -beta, tumor necrosis factor-alpha and transcription factors, IRF-1 and IRF-2, in leukocytes induced during interferon production.
    Lopez-Ocejo O; Herrera A; Herrera L; De la Fuente J
    Biol Res; 1995; 28(4):283-90. PubMed ID: 9251759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of interferon alpha inducible genes in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus and healthy donors.
    MacParland SA; Corkum CP; Burgess C; Karwowska S; Kroll W; Michalak TI
    Int Immunopharmacol; 2015 Apr; 25(2):545-52. PubMed ID: 25765354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells.
    Ronni T; Sareneva T; Pirhonen J; Julkunen I
    J Immunol; 1995 Mar; 154(6):2764-74. PubMed ID: 7876547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
    Abbate I; Romano M; Longo R; Cappiello G; Lo Iacono O; Di Marco V; Paparella C; Spano A; Capobianchi MR
    J Med Virol; 2003 Aug; 70(4):581-7. PubMed ID: 12794720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of interferon regulatory factor (IRF) genes and response to interferon-alpha in chronic myeloid leukaemia.
    Hochhaus A; Yan XH; Willer A; Hehlmann R; Gordon MY; Goldman JM; Melo JV
    Leukemia; 1997 Jul; 11(7):933-9. PubMed ID: 9204971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of interferon-alpha expression by PCR in patients with chronic hepatitis C and hepatitis non-A, non-B.
    Brandt ER; Devenish RJ; Hertzog PJ; Dudley FJ; Linnane AW
    J Gastroenterol Hepatol; 1994; 9(4):373-80. PubMed ID: 7948820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of interferon regulatory factors 2'-5' oligoadenylate synthetase, P68 kinase and RNase L in chronic myelogenous leukaemia cells and its relationship to clinical responsiveness.
    Fischer T; Aman J; van der Kuip H; Rudolf G; Peschel C; Aulitzky WE; Huber C
    Br J Haematol; 1996 Mar; 92(3):595-603. PubMed ID: 8616023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway.
    Kaser A; Enrich B; Ludwiczek O; Vogel W; Tilg H
    Clin Exp Immunol; 1999 Oct; 118(1):71-7. PubMed ID: 10540162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct activation of murine interferon-alpha promoter region by IRF-1/ISFG-2 and virus infection.
    Au WC; Raj NB; Pine R; Pitha PM
    Nucleic Acids Res; 1992 Jun; 20(11):2877-84. PubMed ID: 1614874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of interferon-alpha subtypes on the TH1/TH2 balance in peripheral blood mononuclear cells from patients with hepatitis virus infection-associated liver disorders.
    Ariyasu T; Tanaka T; Fujioka N; Yanai Y; Yamamoto S; Yamauchi H; Ikegami H; Ikeda M; Kurimoto M
    In Vitro Cell Dev Biol Anim; 2005; 41(1-2):50-6. PubMed ID: 15926860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles.
    Pham TN; Mercer SE; Michalak TI
    J Viral Hepat; 2009 Aug; 16(8):547-56. PubMed ID: 19215578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
    van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
    J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of in vitro interferon-beta administration on hepatitis C virus in peripheral blood mononuclear cells as a predictive marker of clinical response to interferon treatment for chronic hepatitis C.
    Mochizuki K; Kagawa T; Takashimizu S; Kawazoe K; Kojima S; Nagata N; Nakano A; Nishizaki Y; Shiraishi K; Itakura M; Watanabe N; Mine T; Matsuzaki S
    World J Gastroenterol; 2004 Mar; 10(5):733-6. PubMed ID: 14991949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
    Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.